Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 6
2015 25
2016 29
2017 37
2018 31
2019 32
2020 25
2021 29
2022 30
2023 30
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria.
Shin JI, Fine DM, Sang Y, Surapaneni A, Dunning SC, Inker LA, Nolin TD, Chang AR, Grams ME. Shin JI, et al. J Am Soc Nephrol. 2022 Sep;33(9):1767-1777. doi: 10.1681/ASN.2022020135. Epub 2022 Jul 19. J Am Soc Nephrol. 2022. PMID: 35853713 Free PMC article.
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M, Larson EA, Roden DM, Klein TE, Yee SW, Krauss RM, Turner RM, Palaniappan L, Gaedigk A, Giacomini KM, Caudle KE, Voora D. Cooper-DeHoff RM, et al. Clin Pharmacol Ther. 2022 May;111(5):1007-1021. doi: 10.1002/cpt.2557. Epub 2022 Mar 11. Clin Pharmacol Ther. 2022. PMID: 35152405 Free PMC article.
Rosuvastatin: Beyond the cholesterol-lowering effect.
Cortese F, Gesualdo M, Cortese A, Carbonara S, Devito F, Zito A, Ricci G, Scicchitano P, Ciccone MM. Cortese F, et al. Pharmacol Res. 2016 May;107:1-18. doi: 10.1016/j.phrs.2016.02.012. Epub 2016 Mar 2. Pharmacol Res. 2016. PMID: 26930419 Review.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators. Yusuf S, et al. N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27040132 Free article. Clinical Trial.
Rosuvastatin-Induced Dysarthria: An Unusual Drug Reaction.
Barus R, Jouvray M, Gautier S, Potey C. Barus R, et al. Ann Pharmacother. 2022 Dec;56(12):1382-1383. doi: 10.1177/10600280221085816. Epub 2022 Apr 7. Ann Pharmacother. 2022. PMID: 35392669 No abstract available.
236 results